Mai Capital Management A Tyr Pharma Inc Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Mai Capital Management holds 215 shares of LIFE stock, worth $399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215Holding current value
$399% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LIFE
# of Institutions
82Shares Held
44MCall Options Held
51.1KPut Options Held
40.3K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.06% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.88MShares$9.08 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.6MShares$6.71 Million0.0% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.33% of portfolio
-
Woodline Partners LP San Francisco, CA1.68MShares$3.13 Million0.02% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...